Optimal combinations of fatty acids and linkers have been identified for maximum binding to albumin and maintaining activity against the GLP-1R [1]
Weekly injections deliver higher absorption rates and consistent dosing, which translates to stronger appetite suppression and more predictable weight loss progress
Prolonged Fullness: Because your stomach is emptying slower, a standard breakfast might keep you feeling satisfied well into the late afternoon
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy volunteers: a dose-escalation phase I study
Some of the most common side effects in clinical trials included nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion (dyspepsia), and stomach (abdominal) pain
Blood Pressure and Lipids Both medications produce similar improvements in cardiovascular risk factors: Blood pressure: Both typically reduce systolic BP by 3-6 mmHg Effects are similar between medications Lipids: Both reduce triglycerides Modest effects on LDL cholesterol Similar lipid improvements Metabolic Comparison Cost and Insurance Cost considerations may influence medication choice for some patients
